Literature DB >> 11268142

Assessment of depression among cancer patients: the role of pain, cancer type and treatment.

A Ciaramella1, P Poli.   

Abstract

One hundred consecutive cancer patients were assessed using two structured methods for assessing major depressive disorder-Structured Clinical Interview for DSM III-R (SCID) and Endicott criteria-and using a depression rating scale-Hamilton Depression Rating Scale (HAMD). Forty-nine percent of patients were depressed using SCID (DSM III-R criteria), whereas 29% of patients were depressed using Endicott criteria. Twenty-eight percent of patients were depressed using both criteria. Age and sex did not have any influence on the assessment of major depression. Both the structured interview and the rating scale were able to identify suicide ideation. Depressed patients were not shown to have more lifetime depression than non-depressed patients using both structured methods. Patients who were depressed using both assessments of depression had more metastasis and pain than non-depressed patients. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268142     DOI: 10.1002/pon.505

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  37 in total

1.  Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life.

Authors:  K Mystakidou; E Tsilika; E Parpa; E Katsouda; A Galanos; L Vlahos
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers.

Authors:  Fu-Ling Zhou; Wang-Gang Zhang; Yong-Chang Wei; Kang-Ling Xu; Ling-Yun Hui; Xu-Sheng Wang; Ming-Zhong Li
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

Review 3.  Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.

Authors:  Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

4.  Performance of four diagnostic approaches to depression in adults with cancer.

Authors:  Rebecca M Saracino; Barry Rosenfeld; Christian J Nelson
Journal:  Gen Hosp Psychiatry       Date:  2018-01-31       Impact factor: 3.238

5.  Functional impairments as symptoms in the symptom cluster analysis of patients newly diagnosed with advanced cancer.

Authors:  Samah J Fodeh; Mark Lazenby; Mei Bai; Elizabeth Ercolano; Terrence Murphy; Ruth McCorkle
Journal:  J Pain Symptom Manage       Date:  2013-02-04       Impact factor: 3.612

Review 6.  Cancer pain and depression: a systematic review of age-related patterns.

Authors:  Lucia Gagliese; Lynn R Gauthier; Gary Rodin
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

7.  Association between hospice care and psychological outcomes in Alzheimer's spousal caregivers.

Authors:  Scott A Irwin; Brent T Mausbach; Derek Koo; Nathan Fairman; Susan K Roepke-Buehler; Elizabeth A Chattillion; Joel E Dimsdale; Thomas L Patterson; Sonia Ancoli-Israel; Paul J Mills; Roland von Känel; Michael G Ziegler; Igor Grant
Journal:  J Palliat Med       Date:  2013-10-05       Impact factor: 2.947

8.  Antidepressant prescribing in community cancer care.

Authors:  Fredrick D Ashbury; Lisa Madlensky; Peter Raich; Mark Thompson; Geoff Whitney; Ken Hotz; Boris Kralj; William S Edell
Journal:  Support Care Cancer       Date:  2003-03-06       Impact factor: 3.603

9.  Reduction of depression symptoms in laryngeal cancer patients receiving psychology services.

Authors:  Shanshan Zhang; Haina Chen; Min Zhang; Xiaoyan Sun; Xiaoying Liu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  Age and sex dependencies of anxiety and depression in cardiologic patients compared with the general population.

Authors:  Andreas Hinz; Jörg Kittel; Marthin Karoff; Reinhold Schwarz
Journal:  Psychosoc Med       Date:  2004-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.